PRNewsWire
07 Nov 2026, 00:38 UTC · 1h ago
TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law
Impact · against what's priced in
The failure of the Phase 3 LEVEL trial is a catastrophic value-destroying event that has already triggered a 90% price collapse. The subsequent announcement of a fraud investigation by SBS Law adds a layer of legal liability but is a secondary effect of the primary clinical failure.
- TENX−0.30
No priced-in read yet





